TRUE Gene Silencing.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 May 2022
Historique:
received: 11 04 2022
revised: 09 05 2022
accepted: 10 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

TRUE gene silencing is an RNA-mediated gene expression control technology and is termed after tRNase Z

Identifiants

pubmed: 35628198
pii: ijms23105387
doi: 10.3390/ijms23105387
pmc: PMC9141469
pii:
doi:

Substances chimiques

MicroRNAs 0
RNA Precursors 0
RNA, Guide 0
RNA, Transfer 9014-25-9
Endoribonucleases EC 3.1.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : the Promotion and Mutual Aid Corporation for Private Schools of Japan
ID : the Science Research Promotion Fund

Références

Nucleic Acids Res. 1993 Oct 11;21(20):4696-702
pubmed: 8233818
RNA. 1996 Jun;2(6):523-4
pubmed: 8718682
PLoS One. 2015 Mar 02;10(3):e0118631
pubmed: 25730316
Noncoding RNA Res. 2019 Nov 22;4(4):135-140
pubmed: 32072081
Science. 2016 Jan 22;351(6271):391-396
pubmed: 26721685
Biochem Biophys Res Commun. 2009 Feb 20;379(4):924-7
pubmed: 19135977
Mol Ther. 2021 Feb 3;29(2):540-554
pubmed: 33359792
Leukemia. 2018 Feb;32(2):252-262
pubmed: 29257139
J Vis Exp. 2016 Jun 02;(112):
pubmed: 27285342
Mol Ther. 2021 Feb 3;29(2):431-432
pubmed: 33472033
Nucleic Acids Res. 2003 May 1;31(9):2272-8
pubmed: 12711671
PLoS One. 2012;7(6):e38496
pubmed: 22675569
Front Immunol. 2020 Jun 05;11:1128
pubmed: 32582204
FEBS Lett. 2000 Apr 28;472(2-3):179-86
pubmed: 10788607
Blood Cells Mol Dis. 2021 Feb;86:102503
pubmed: 32920464
Nucleic Acids Res. 1995 Sep 25;23(18):3642-7
pubmed: 7478991
Mol Ther. 2021 Feb 3;29(2):521-539
pubmed: 33188937
Leuk Res. 2014 Jul;38(7):729
pubmed: 24875835
Nucleic Acids Res. 2020 Aug 20;48(14):7623-7639
pubmed: 32644123
Blood Cells Mol Dis. 2019 Nov;79:102341
pubmed: 31226499
PLoS One. 2014 Dec 01;9(12):e114121
pubmed: 25437003
PLoS One. 2009 Jun 15;4(6):e5908
pubmed: 19526060
Nucleic Acids Res. 2004 Aug 18;32(15):4429-38
pubmed: 15317868
J Mol Biol. 1999 Apr 9;287(4):727-40
pubmed: 10191141
Nucleic Acids Res. 1998 Jun 1;26(11):2565-72
pubmed: 9592138
Nucleic Acids Res. 2003 Aug 1;31(15):4354-60
pubmed: 12888494
Leuk Res. 2014 Jul;38(7):808-15
pubmed: 24768135
Biochemistry. 1999 Sep 14;38(37):12089-96
pubmed: 10508413
Leuk Res. 2013 May;37(5):580-5
pubmed: 23403166
Cell Rep. 2020 Feb 18;30(7):2106-2114.e5
pubmed: 32075755
Biochem Biophys Res Commun. 1991 Aug 15;178(3):1247-52
pubmed: 1872844
Gene Ther. 2007 Jan;14(1):78-85
pubmed: 16885998
Noncoding RNA Res. 2017 Jul 26;2(2):122-128
pubmed: 30159430
Nucleic Acids Res. 2004 Jun 28;32(11):e91
pubmed: 15247324
Noncoding RNA Res. 2019 Dec 17;5(1):37-40
pubmed: 32206739
Biochem Biophys Rep. 2021 Feb 02;26:100918
pubmed: 33553691
J Biol Chem. 2005 Jun 10;280(23):22326-34
pubmed: 15824113
Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):427-32
pubmed: 22142845
Nucleic Acids Res. 1999 Jul 1;27(13):2770-6
pubmed: 10373595
FEBS Lett. 2009 Oct 6;583(19):3241-6
pubmed: 19751732
Nucleic Acids Res. 2005 Jan 12;33(1):235-43
pubmed: 15647506
Cancer Lett. 2013 Jan 28;328(2):362-8
pubmed: 23092557
Nucleic Acids Res. 1997 Mar 15;25(6):1148-54
pubmed: 9092623
Nucleic Acids Res. 1992 Jul 25;20(14):3737-42
pubmed: 1641339
Biochem Biophys Res Commun. 1991 May 15;176(3):1163-9
pubmed: 2039502

Auteurs

Masayuki Nashimoto (M)

Research Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Niigata 956-8603, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH